European Journal of Medicinal Chemistry p. 547 - 570 (1997)
Update date:2022-08-04
Topics:
Griera
Armengol
Reyes
Alvarez
Palomer
Cabre
Pascual
Garcia
Mauleon
This paper describes the synthesis and pharmacological evaluation of three series of compounds 4a-b, 13a-k and 19, structurally related to the known potent cysLT1 receptor antagonists RG-12553, IC1-204219 and ONO-1078, respectively. The common structural feature of these new series is the presence of a 4-quinolone nucleus acting as a template for substitution of the aromatic nucleus present in the prototype antagonists. We describe the evolution of these series leading to antagonists with potency at nanomolar concentrations in vitro.
View MoreMerit Special New Material Co., Ltd.
website:http://www.ycmerit.com
Contact:13585104388
Address:No.15 Xiexin Road,Funing Economic Development Zone,JiangSu,P.R.China
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
JIANGXI ZHANGFENG CHEMICAL CO., LTD.
Contact:+86-0799-3413066
Address:Xiyuan village, Xiabu Town, Xiangdong District
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Doi:10.1021/om5002217
(2014)Doi:10.1021/jo01144a018
(1951)Doi:10.1021/jm00222a002
(1977)Doi:10.1139/v96-282
(1996)Doi:10.1007/BF00778173
()Doi:10.3390/molecules201018565
(2015)